FactaeThe Factual News

Top Stories Focus Media

Monde
France
Régional
Politique
Guerre
Défense & Sécurité

Économie
Marchés
Énergie
Crypto

Tech
Intelligence artificielle
Informatique
Cybersécurité

Science
Santé
Écologie

Histoire
Culture
Sport
Droit
Éducation

Factae

The Factual News

The intelligence of the news. Multi-source, geolocated, synthesized.

Live

Live feed Scoops Immersive map

Explore

Trading Board Trends AI models AI tools Sources

Information

About Methodology RSS feed Contact Terms Privacy Legal Newsletter

© 2026 Factae. All rights reserved.

Innate Pharma reassures on financing with its ATM program | Factae

Innate Pharma reassures on financing with its ATM program

Innate Pharma rules out financing risks thanks to its ATM program.

Published 4j·1 source

Lire en français

≈ 15sSpeed

The fact

The biotech firm maintains research projects without additional fundraising.

Shareholders welcome this financial stability amid market tensions.

🔗Click the link to read an article on the topic:

🧭Explore this topic

Marseille France Innate Pharma #innate pharma #biotech #financement #atm #marchés financiers #recherche médicale #bourse

What if you saw the whole news differently?Factae cross-checks hundreds of sources worldwide to keep only the fact, no opinion. Explore the front page.→

MarseilleWorld map →

Follow topic →

Auto-synthesis from 1 media source · identified on July 17, 2026

← Back to home

Discover

Read more

All marches →

Clôture de l'action Abivax à 127 euros le 2 juillet 2026 sur Boursorama

2sem · 1 source marches

Innate Pharma falls despite positive news releases

13sem · 1 source sante

Innate Pharma: volatility in French immunotherapy biotech stock

13sem · 1 source marches

Innate Pharma: investment analysis on French biotech future

14sem · 1 source marches

Innate Pharma: shareholders demand fair pricing

1sem · 1 source marches

Innate Pharma: IPH5201 results to watch for funding implications

13sem · 1 source